DashboardPortfoliosFavoritenGemeinschaftEntdeckenSuchen
NOT FOR DISTRIBUTION
Loading...
  • Bestände
  • /
  • Diversifizierte Finanzdaten
Vor 5h aktualisiert
AFCG logo

Advanced Flower Capital Inc.NasdaqGM:AFCG Aktienübersicht

Marktkapitalisierung US$80.5m
Vor 5h aktualisiert
Aktienkurs
n/a
1Y-23.7%
7D-0.6%
1D4.7%
Wert des Portfolios
​
Siehe

Advanced Flower Capital Inc.

NasdaqGM:AFCG Lagerbericht

Marktkapitalisierung: US$80.5m

  • Unternehmensüberblick
    • Bewertung
    • Ausblick und Wachstum
    • Leistungs-Rückblick
    • Finanzlage
    • Dividende
  • Management
  • Eigentümerschaft
  • Weitere Informationen
  • Aktien-Community

Advanced Flower Capital (AFCG) Aktienübersicht

Advanced Flower Capital Inc. vergibt, strukturiert, zeichnet, investiert und verwaltet vorrangig besicherte Darlehen und andere Arten von Hypothekendarlehen und Schuldverschreibungen für etablierte Unternehmen, die in der Cannabisbranche tätig sind. Mehr Details

AFCG grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung1/6
Künftiges Wachstum3/6
Vergangene Leistung0/6
Finanzielle Gesundheit1/6
Dividenden2/6

Belohnungen

Prognostiziertes Gewinnwachstum 38.86% pro Jahr

Risikoanalyse

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt

Die Dividende von 5.63% ist nicht gut durch Erträge oder freie Cashflows gedeckt

Hat keine nennenswerte Marktkapitalisierung ($80M)


AFCG Community Fair Values

Create Narrative

See what 33 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
55.6% unterbewertet intrinsischer Abschlag
AnalystConsensusTarget
•2mo ago

BDC Conversion And Federal Shifts Will Expand Lending Across Sectors

194
0
17
AN
AnalystLowTarget
21.1% unterbewertet intrinsischer Abschlag
AnalystLowTarget
•1y ago

Cannabis Credit Risks Will Disrupt Lending While Modest Recovery Emerges

20
0
2
AN
AnalystHighTarget
72.7% unterbewertet intrinsischer Abschlag
AnalystHighTarget
•1y ago

Global Cannabis Legalization Will Unlock Diverse Lending Opportunities

34
0
2

Top Analyst Narratives

AN
AnalystConsensusTarget
55.6% unterbewertet intrinsischer Abschlag
AnalystConsensusTarget
•2mo ago

BDC Conversion And Federal Shifts Will Expand Lending Across Sectors

194
0
17
AN
AnalystLowTarget
21.1% unterbewertet intrinsischer Abschlag
AnalystLowTarget
•1y ago

Cannabis Credit Risks Will Disrupt Lending While Modest Recovery Emerges

20
0
2
AN
AnalystHighTarget
72.7% unterbewertet intrinsischer Abschlag
AnalystHighTarget
•1y ago

Global Cannabis Legalization Will Unlock Diverse Lending Opportunities

34
0
2
View all narratives

Advanced Flower Capital Inc. Wettbewerber

Alpha G Investment Management

Symbol: OTCPK:TETA.A
Market cap: US$23.7m

Innventure

Symbol: NasdaqGM:INV
Market cap: US$79.2m

Heritage Global

Symbol: NasdaqCM:HGBL
Market cap: US$48.8m

BKF Capital Group

Symbol: OTCPK:BKFG
Market cap: US$54.8m

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für Advanced Flower Capital
Historische Aktienkurse
Aktueller AktienkursUS$3.55
52-Wochen-HochUS$4.70
52-Wochen-TiefUS$2.06
Beta1.0
1 Monat Veränderung12.34%
3 Monate Veränderung4.72%
1 Jahr Veränderung-23.66%
3 Jahre Veränderung-72.86%
5 Jahre Veränderung-83.57%
Veränderung seit IPO-84.57%

Aktuelle Nachrichten und Updates

Seeking Alpha • Sep 01

Advanced Flower Capital: Deep Discount To NAV On Share Repurchases

Summary Advanced Flower Capital trades at a 56% discount to NAV per share despite a 4.4% sequential NAV increase to $8.25 per share. AFCG's dividend is 300% covered by net investment income, but management is prioritizing accretive share buybacks over dividend hikes. The portfolio remains 73.7% exposed to cannabis debt, with 22.7% of assets on non-accrual, sustaining market skepticism. I rate AFCG as Hold due to persistent cannabis loan risks and potential for further non-accruals, despite strong capital management. Read the full article on Seeking Alpha
User avatar
Narrative-Update • Jun 26

AFCG: Share Repurchase Program Will Drive Long-Term Upside Potential

Analysts have raised the price target on Advanced Flower Capital from $5.25 to $8.00, citing updated assumptions about its discount rate, profit margin outlook, and future P/E as key drivers of the revised valuation. What’s in the News for Advanced Flower Capital Advanced Flower Capital Inc.

Recent updates

Seeking Alpha • Sep 01

Advanced Flower Capital: Deep Discount To NAV On Share Repurchases

Summary Advanced Flower Capital trades at a 56% discount to NAV per share despite a 4.4% sequential NAV increase to $8.25 per share. AFCG's dividend is 300% covered by net investment income, but management is prioritizing accretive share buybacks over dividend hikes. The portfolio remains 73.7% exposed to cannabis debt, with 22.7% of assets on non-accrual, sustaining market skepticism. I rate AFCG as Hold due to persistent cannabis loan risks and potential for further non-accruals, despite strong capital management. Read the full article on Seeking Alpha
User avatar
Narrative-Update • Jun 26

AFCG: Share Repurchase Program Will Drive Long-Term Upside Potential

Analysts have raised the price target on Advanced Flower Capital from $5.25 to $8.00, citing updated assumptions about its discount rate, profit margin outlook, and future P/E as key drivers of the revised valuation. What’s in the News for Advanced Flower Capital Advanced Flower Capital Inc.
User avatar
Narrative-Update • Mar 05

AFCG: Index Removals And BDC Shift Will Create Long-Term Upside Potential

Analysts have adjusted their fair value estimate for Advanced Flower Capital from $6.88 to $5.25, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E levels. What's in the News On January 13, 2026, Advanced Flower Capital entered into Amendment Number Six to its Loan and Security Agreement, reflecting updates linked to its conversion from a real estate investment trust to a business development company (Key Developments).
User avatar
Narrative-Update • Nov 12

AFCG: Conversion To BDC Structure Will Unlock Leverage Potential By 2026

Analysts have revised Advanced Flower Capital's fair value estimate downward from $8.13 to $6.88. This change is due to updated assumptions regarding profitability metrics and increased discount rates.
User avatar
Narrative-Update • Aug 16

I Will Capitalize On Cannabis Debt Demand By Diversifying Portfolio And Improving Underwriting

Despite a dramatic increase in revenue growth forecasts and a lower projected future P/E, the consensus analyst price target for Advanced Flower Capital has been revised downward from $8.76 to $7.50. What's in the News Advanced Flower Capital declared a quarterly dividend of $0.15 per common share for the quarter ending June 30, 2025, payable on July 15, 2025 to shareholders of record on June 30, 2025.
Seeking Alpha • Mar 28

Advanced Flower Capital Stock: The Bull Case After A Brutal Sell-Off

Summary Advanced Flower Capital's Q4 earnings report led to a 20%+ stock drop in a single day due to a dividend cut from $0.33 to $0.23 per share. Despite borrower issues, AFCG offers a 14.6% yield and trades at 0.7x book value, presenting a potential investment opportunity. Management's ability to recover and redeploy capital from troubled loans is crucial for sustaining dividends and improving distributable earnings. I have issues with pre-set origination targets and the lack of borrower transparency, making AFCG a cautious buy with limited allocation. Read the full article on Seeking Alpha
Seeking Alpha • Mar 13

Advanced Flower Capital Has A Solid Dividend And A Lot Of Near-Term Growth Opportunities

Summary Advanced Flower Capital is a REIT specializing in loans to state-licensed cannabis operators, offering a strong dividend yield of ~15.5%. The cannabis market is growing, with 41 states legalizing medical cannabis and 24 states legalizing recreational use, projecting $100B in future annual sales. Using a conservative Dividend Discount Model, AFCG's per share value is estimated at $10.79, indicating a 28.42% increase from the current price, making it an attractive investment. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

Advanced Flower Capital: Get Paid 13.7% Per Year As The Cannabis Market Grows

Summary Advanced Flower Capital offers a 13.7% dividend yield, which is covered by its distributable earnings per share. AFCG's cautious underwriting and strategic equity raises ensure resilience and capitalize on current market opportunities, despite potential regulatory changes. AFCG stock's valuation remains attractive with a price/book ratio near 1.0x and a 13.7% yield, though short-term downside risk exists based on my technical analysis. Long-term investors can likely see a mix of stable income and growth potential as interest rates fall and the cannabis market expands. Read the full article on Seeking Alpha
User avatar
Neues Narrative • Sep 26

Cannabis Sector Focus Sparks Revenue Growth And Enhances Shareholder Value

Focusing solely on the cannabis sector post-spin-off, AFC Gamma aims for higher returns through an increased focus, positively impacting revenue.
Seeking Alpha • Sep 15

AFC Gamma declares $0.56 dividend

AFC Gamma (NASDAQ:AFCG) declares $0.56/share quarterly dividend, in line with previous. Forward yield 12.9% Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept. 29. See AFCG Dividend Scorecard, Yield Chart, & Dividend Growth.
Seeking Alpha • Aug 16

AFC Gamma: 11.20% Dividend Yield With Solid Q2 2022 Results

AFC Gamma has a strong dividend yield of 11.20% with quarterly dividend increasing 55% since March 2021. AFCG posted solid Q2 2022 results beating the market EPS estimates by 20% and revenue estimates by 13%. I assign a buy rating for the company after considering all the growth and risk factors. Investment Thesis AFC Gamma, Inc. (AFCG) is a leading lender of institutional loans to nationwide cannabis producers and distributors. AFCG is headquartered in West Palm Beach, Florida. In this thesis, I will be discussing about the company's strong dividend yield. I will also be analyzing the second quarter results posted by the company and its future growth prospects. I assign a buy rating for AFCG after considering all the growth and risk factors. Company Overview AFCG is a mortgage real estate investment trust ((REIT)), primarily lending loans to high-quality cannabis cultivators, producers, and distributors in the United States. The company is especially known for having a well-balanced lending portfolio, safeguarding the company from volatile markets. The company provides secured loans backed by significantly higher in value collateral. It generally provides loans to well-established companies having considerable cash flows, limiting the company's risk exposure. 11.20% Dividend Yield TipRanks AFCG has a strong dividend yield of 11.20% at current share price of $18.22. As we can see in the chart above, the dividend payout has been consistently increasing since March 2021. The dividend per share has seen a 55% growth from $0.36 in March 2021 to $0.56 in June 2022. Along with the increased dividend payout, the dividend yield has also increased from 7%-8% in March 2021 to 11%-12% currently. I believe with the growing cannabis market and reduced uncertainties around the legalization of cannabis, the company is on a significant growth track with limited downside risk. Solid Q2 2022 Results AFCG recently posted solid Q2 2022 results beating the market estimates. The company beat the EPS estimates by 20% and revenue estimates by 13%. It experienced improvement across segments with improved profit margins. I believe the company is on a significant growth track, and that is clearly reflected in the Q2 2022 results. The company is positive about the coming quarters and expects to expand its loan portfolio. SEC:10Q AFCG AFCG reported an Interest income of $21.6 million, a significant 148% jump compared to $8.7 million in the same quarter last year. As per my analysis, the expansion in the mortgage portfolio and well-balanced loan spread were the primary factors behind this increase. The company reported total expenses of $5.7 million, a 90% increase. I believe the increase in human resources and expenses related to human resource management were the main reasons behind the increased expenses. The total net income stood at $11.3 million, a solid 62% net profit margin. The diluted EPS was reported at $0.57 against the Q2 2021 EPS of $0.34, an effective increase of 67%. I believe the company will continue this performance in the coming quarters with continuous expansion and a well-balanced lending portfolio. Leonard Tannenbaum, AFC Gamma's Chief Executive Officer, stated, Given the current market environment with operators experiencing pricing pressures and longer lead times to raise equity, we continue to act disciplined in our approach towards deploying capital. We are focused on supporting existing operators as well as new operators with strong track-records in the industry. Despite the slower than expected pace of originations, we have the capacity to do more deals and expect to close some in the coming quarter. We look forward to continue supporting the industry as it expands and matures. Overall, AFCG posted strong quarter with improved margins and increased lending portfolio. The company has not provided any guidance for the future quarters but I estimate the FY22 EPS to be in the range of $2.26-$2.32. The company is well positioned in the industry to capitalize on the growing cannabis market and we can witness a significant upside in the stock price in the near future. Key Risk Factor
Seeking Alpha • Aug 08

AFC Gamma Q2 2022 Earnings Preview

AFC Gamma (NASDAQ:AFCG) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open. The consensus EPS Estimate is $0.55 (+27.9% Y/Y) and the consensus Revenue Estimate is $17.58M Over the last 1 year, AFCG has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 5 downward. Revenue estimates have seen 3 upward revisions and 3 downward.
Seeking Alpha • Jun 08

AFC Gamma Capitalizes On Blooming Cannabis Industry

14.5% dividend yield with our estimated fair value at $24. Overcollateralized (1.1x principal) commercial mortgage portfolio valued at $483 million. Massive cannabis market CAGR, growing dividend by 10% quarter over quarter – marking the third consecutive quarterly increase. Stringent selection criteria going beyond traditional commercial mortgages, giving a favorable risk profile.

Aktionärsrenditen

AFCGUS Capital MarketsUS Markt
7D-0.6%-3.3%-0.9%
1Y-23.7%1.7%13.9%

Rendite im Vergleich zur Industrie: AFCG unter dem Niveau der Branche US Capital Markets , die im vergangenen Jahr eine Rendite von 1.7% erzielte.

Rendite vs. Markt: AFCG hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 13.9 erzielte.

Preisvolatilität

Is AFCG's price volatile compared to industry and market?
AFCG volatility
AFCG Average Weekly Movement6.7%
Capital Markets Industry Average Movement3.3%
Market Average Movement6.9%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market2.9%

Stabiler Aktienkurs: AFCG hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: AFCGDie wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
2020n/aDan Nevilleadvancedflowercapital.com

Advanced Flower Capital Inc. vergibt, strukturiert, zeichnet, investiert und verwaltet vorrangig besicherte Darlehen und andere Arten von Hypothekendarlehen und Schuldverschreibungen für etablierte Unternehmen, die in der Cannabisbranche tätig sind. Das Unternehmen vergibt in erster Linie Kredite, die als vorrangige Darlehen strukturiert sind und durch Immobilien, Ausrüstung, Cashflows und Lizenzen und/oder andere Vermögenswerte der Kreditnehmer gesichert sind, soweit dies nach den geltenden Gesetzen und den für diese Kreditnehmer geltenden Vorschriften zulässig ist. Das Unternehmen war früher unter dem Namen AFC Gamma, Inc. bekannt und änderte im Oktober 2024 seinen Namen in Advanced Flower Capital Inc. um.

Advanced Flower Capital Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Advanced Flower Capital im Vergleich zum Marktanteil des Unternehmens?
AFCG grundlegende Statistiken
MarktanteilUS$80.49m
Gewinn(TTM)-US$3.41m
Umsatz(TTM)US$19.14m
4.2x
Kurs-Umsatz-Verhältnis
-23.6x
Kurs-Gewinn-Verhältnis

Ist AFCG zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
AFCG Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$19.14m
Kosten der EinnahmenUS$0
BruttogewinnUS$19.14m
Sonstige AusgabenUS$22.55m
Gewinn-US$3.41m

Zuletzt gemeldete Gewinne

Jun 30, 2026

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)-0.15
Bruttomarge100.00%
Nettogewinnspanne-17.84%
Schulden/Eigenkapital-Verhältnis110.3%

Wie hat sich AFCG auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

5.6%
Aktuelle Dividendenrendite
-168%
Ausschüttungsquote

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/09/14 07:33
Aktienkurs zum Tagesende2026/09/11 00:00
Gewinne2026/06/30
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
  • SEC-Formular 10-K
  • SEC-Formular 10-Q
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
  • Analysten Research Berichte
  • Blue Matrix
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
  • ICE-Marktdaten
  • SEC-Formular S-1
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
  • SEC-Formular 4
  • SEC-Formular 13D
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
  • SEC-Formular 10-K
  • SEC-Formular DEF 14A
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens
  • SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Advanced Flower Capital Inc. wird von 5 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Aaron GreyAlliance Global Partners
Matthew HurwitJefferies LLC
Christopher Whitbread NolanLadenburg Thalmann & Company

Triff überall bessere Investmententscheidungen

Zum Herunterladen scannen
App Store öffnenGoogle Play öffnen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Datenquellen anzeigen
Märkte
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideen für Investitionen
  • Unterbewertete Unternehmen
  • Dividendenstarke Unternehmen
  • Insider-Käufe
  • Kernenergie
  • Autonome Fahrzeuge
  • Künstliche Intelligenz
  • Kryptowährung und Blockchain
  • Cybersicherheit
  • Weitere Ideen
Börsengemeinschaften
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Werkzeuge und Funktionen
  • Portfolio-Tracker
  • Aktien-Screener & Alarme
  • Erzählungen & faire Werte
  • Dividenden-Rechner
Nachrichten & Entdeckungen
  • Neueste Bestandsnachrichten
  • Globale Markteinsichten
  • Der Fuchsbau
  • Ideen für Investitionen
  • Community-Erzählungen
  • Was gibt's Neues?
Simply Wall St
  • Pläne & Preisgestaltung
  • Werbung},{
  • Über uns
  • Kontakt
  • Karriere
  • Hilfe-Center
  • Lernen Sie das Investieren in Aktien
  • Partnerprogramm
  • Business & Unternehmen
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Bedingungen und Konditionen
  • Datenschutzbestimmungen
  • KI-Bedingungen
  • Leitfaden für Finanzdienstleistungen